13.07.2015 Views

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Genelux GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Drug Development, Clinical Diagnostics, Drug Delivery,Immune Therapy, OncologyGenelux Corp., San Diego, CA, US, was founded in 2001. Its assets are builton its founder‘s experience on genetically modified light-emitting bacteria,viruses and mammalian cells:Luminescent or fluorescently labelled microorganisms, when injected intotumor bearing mice, specifically colonize tumors plus metastases and canbe imaged. They grow and replicate within the tumors. Tumors are remitted.These scientific results should enable diagnosis and treatment of cancer,combining in vivo imaging (diagnostics) with bacteria/virus induced tumorregression (therapy), and should add a potent theragnostic alternative toexisting therapies and diagnostics.Genelux GmbH, Bernried, Germany, was established mid 2004 and aims totranslate the scientific results into commercial services and products.Contact:Dr. Albert RöderAm Neuland 1D-82347 BernriedPhone: +49 (0) 8158 9223-0Fax: +49 (0) 8158 9223-35E-Mail: a.roeder@genelux.deInternet: www.genelux.deGenetic ID (Europe) AG –Labor für gentechnische AnalysenBIOTECH DNA/PROTEIN ANALYTICSKeywords: ELISA / EIA, Genomics, PCR, Analysis, Laboratory,Transgenic Plants, AgrobiotechnologyGenetic ID is a global leader in testing for the presence of genetically modifiedorganisms (GMOs) in food and agricultural products. In additionGenetic ID also offers Allergen screening.Founded in 1996, Genetic ID Inc. maintains global headquarters in USA, aswell as premier testing laboratories in Japan and Germany, offices in Brazil,and the Global Laboratory Alliance of affiliated laboratories and representativesspanning five continents.We develop technologies that address all aspects of the GMO-testing segmentand provide all clients with the technology, services and informationthey need to operate in the increasingly high-tech global marketplace.Contact:William F. ThompsonAm Mittleren Moos 48D-86167 AugsburgPhone: +49 (0) 821 74776-30Fax: +49 (0) 821 74776-39E-Mail: info-europe@genetic-id.comInternet: www.genetic-id.deGeneWake GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Genomics, Oncology, Clinical Diagnostics, PharmacogenomicsGeneWake GmbH is a pharmacogenomics company focussed on biomarkeranalysis in the field of oncology. Our mission is to realize a personalizedcancer treatment by targeted analysis of relevant gene expression levels intumour tissue and circulating tumour cells. By employing bioinformaticalalgorithms based on our thorough knowledge in pathways and publicmicroarray data sources, biomarker screening can be limited to a lowdensityscale. These genomic tests can be used for patient stratification ortherapy tracking. GeneWake also offers contract research like sequencing,annotation, SNP genotyping, mutation detection, multiplex PCR, immunehistology and genotyping for clinical studies.Contact:Dr. Robert LoeweFloriansbogen 2-4D-82061 NeuriedPhone: +49 (0) 89 74419-166Fax: +49 (0) 89 74419-164E-Mail: info@genewake.comInternet: www.genewake.com65

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!